Previous Page  4 / 8 Next Page
Information
Show Menu
Previous Page 4 / 8 Next Page
Page Background

Journal of sexual and Reproductive medicine

|

Volume.1, Issue.2

Page 10

Notes:

3

rd

International Congress on

Annual Summit on

October 02-03, 2017 Atlanta,USA

&

Microbiology and Pharmaceutical Microbiology

Sexual & Reproductive Health

Ian James Martins

Edith Cowan University, Australia

Bacterial lipopolysaccharides (LPS) accelerates diabetes: Acute epilepsy and

neurodegenerative disease

D

iabetes in the world has reached epidemic proportions with mitochondrial disease related to programmed

cell death in various cells. The nuclear-mitochondrial interaction in diabetes is defective with concerns

that increased plasma levels of bacterial lipopolysaccharides (LPS) are involved in mitochondrial disease and

programmed cell death. Western diets with overnutrition promote LPS absorption with increased plasma LPS

levels. Drug therapy in diabetes has become essential to prevent mitochondrial disease but LPS effects override the

drug therapeutic effects withmitochondrial apoptosis. LPS inserts itself into cell membranes and is now considered

a major repressor of the anti-aging gene

Sirtuin 1

(

Sirt 1

) and is a competitive inhibitor of

Sirt 1

actions involved

in the regulation of cholesterol and glucose homeostasis. LPS neutralizes apolipoprotein E relevant to membrane

amyloid beta aggregation in diabetes and neurodegenerative diseases. Diagnosis of diabetes, dyslipidemia and

nonalcoholic fatty liver disease may now involve plasma LPS levels in global communities to avoid inadvertent

errors by other clinical tests. Healthy diets that activate

Sirt 1

actions are essential reverse chronic diseases in

diabetes with low calorie diets essential to reduce LPS effects. Poor hygiene, skin lesions, microbiological food

contamination and elevated intestinal LPS transport induce LPS mediated mitochondrial apoptosis that supersede

adenosine treatment relevant to recurrent epilepsy and seizures in diabetes and neurodegenerative diseases.

Biography

Ian James Martins has been invited to join the editors of various international journals and has been a reviewer for various journals (approx. 40). He was appointed

as the Chief Editor for

International Journal of Diabetes Research

(2014-2017). He is a BIT Member (BIT Congress. Inc) with an H-index of 42, (ResearchGate

STATs (22), Mendeley STATS (20). The total citations over the past 27 years has accumulated to 2830. ResearchGate’s analysis available on google, Tweet,

Facebook, LinkedIn. He has received certificates of recognition at various conferences/congresses in relation to anti-aging medicine. Prevention of over eating by

food restriction improves the peripheral sink hepatic a beta clearance relevant to liver lipid metabolism important to improving health and global chronic diseases.

i.martins@ecu.edu.au